Thursday 8 |  September 2016


LifeSciences BC McCarthy Spotlight Speaking Series on "Leading Small Teams"
September 22, 2016

LifeSciences BC is pleased to feature the Sauder School of Business, STEMCELL Technologies Inc., AbCellera at our McCarthy Spotlight Speaking Event on
Leading Small Teams  

Event Topic: How to successfully manage and lead small teams or groups, whether in the context of a biotech start-up or within a larger life sciences organization.
Sub-Topics Covered:
*    Theoretical approaches and key principles of leadership from a corporate perspective; presentation by Dr. Michael Daniels, Assistant Professor, Organizational Behaviour & Human Resources, Sauder School of Business, UBC.
*    How to successfully choose your business leaders, how to assign roles for key individuals within your life science business and how to successfully transition from founder and scientist to CEO; presentation by Carl Hansen, CEO of AbCellera;
*    Successful leadership of (small) teams/groups at any level within a large life science enterprise; presentation by Kim Lucas, Director of Sales, Americas at STEMCELL Technologies Inc.

Event Details

Date: September 22, 2016
Time: 4:30 - 7:30 PM
Location: Terminal City Club, 837 West Hastings, Vancouver
For Information Contact:
Sarah Wuertz, Manager, Operations & Events
LifeSciences BC
Phone: 604-669-9909 Ext. 104


LifeSciences BC 2016 AGM and Sponsors' & Members' Appreciation Luncheon

Date: Thursday, September 15th 2016
Time11:30 to 13:30
Location:  Terminal City Club - 837 West Hastings Street, Vancouver
Please note that the AGM is free to attend; however, it's strictly limited to members and sponsors only. After the AGM has concluded, LifeSciences BC is pleased to welcome members, sponsors and non-members to our Sponsors' & Members'
Appreciation Luncheon is free for members and sponsors
 GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies' T-Cell reagents
Exclusive licensing agreement will provide cGMP grade reagents to further enable development and manufacturing of cellular immunotherapies
CHALFONT ST GILES, UK, August 23, 2016 - In a further step to build its portfolio for the rapidly-growing cell therapy industry, GE Healthcare today announced an agreement with STEMCELL Technologies Inc. of Vancouver, Canada to provide T-Cell reagents for commercial-scale cell therapy production.

Aquinox Pharmaceuticals Initiates Patient Dosing in LEADERSHIP 301 Phase 3 Clinical Trial of AQX-1125 in Interstitial Cystitis/Bladder Pain Syndrome

VANCOUVER, British Columbia, Sept. 06, 2016 (GLOBE NEWSWIRE) - Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that it has initiated dosing in a Phase 3 clinical trial of AQX-1125 for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS).

Aspect Biosystems Closes An Oversubscribed Financing

VANCOUVER, BC, Canada - September 6, 2016 - Aspect Biosystems Ltd., a privately held biotechnology company operating at the leading edge of 3D bioprinting and tissue engineering, today announced the completion of an oversubscribed financing.

A spect Biosystems Awarded Canadian Government NRC-IRAP Funding

VANCOUVER, BC, Canada - September 6, 2016 - Aspect Biosystems Ltd. is pleased to announce that it has been awarded $450,000 CAD in grant funding by the National Research Council-Industry Research Assistance Program ("NRC-IRAP") to further advance the development of its Lab-on-a-Printer™ platform technology and associated 3D bioprinted tissue applications.

DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer

DelMar will hold a Business Update Call for Shareholders on Wednesday September 7, 2016 at 5 p.m. EDT

VANCOUVER, British Columbia and WALNUT CREEK, Calif., Sept. 7, 2016 /PRNewswire/ - DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) ("DelMar"), a company focused on developing and commercializing proven cancer therapies in new orphan drug indications, and Accurexa Inc. (OTCQB: ACXA) ("Accurexa"), a company focused on the development of novel neurological therapies to be directly delivered into the brain, announced today a collaboration to develop a novel formulation for the local delivery of combination chemotherapy for the treatment of brain cancer and other solid tumors.

Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

BURNABY, British Columbia, Sept. 07, 2016 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common shares pursuant to its existing shelf registration statement and corresponding Canadian base shelf prospectus.

Xenon Pharmaceuticals Announces Pricing of $30 Million Public Offering of Common Shares

B URNABY, British Columbia, Sept. 08, 2016 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced the pricing of a $30 million underwritten public offering of its common shares pursuant to its existing shelf registration statement and corresponding Canadian base shelf prospectus at a public offering price of $7.50 per share.

Priority review for Merck's Keytruda in first-line NSCLC

September 8, 2016 | By Selina McKee | US regulators have agreed to undertake a priority review of Merck's application to market its immunotherapy Keytruda for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumours express PD-L1.

U.S. CMO buys AstraZeneca U.K. plant, saves 210 jobs 

Sep 6, 2016 | by Eric Palmer | U.S. CMO Avara Pharmaceutical Services is on a roll, or a roll-up. It has struck a deal to buy a plant in the U.K. that AstraZeneca ($AZN) was set to close, saving more than 200 jobs in the process.

Takeda launches scheme to monitor inflammatory bowel disease with wearables

Sep 7, 2016 | by Amirah Al Idrus | Takeda announced on Wednesday that it is partnering with Vanderbilt University and Texas Digestive Disease Consultants (TDDC) on a digital program to help patients and physicians manage inflammatory bowel disease.




Did you know that intelligence is inherited from mothers?

Sept.  5, 2016 | By Jennifer Delgado, Psychology Spot | Smart people should thank their mothers because, according to researchers, their mothers are responsible for the transmission of the intelligence genes.

Cluster or coincidence? Biostatistician weighs in on Elmvale Acres MS cluster claim
Concentration of cases in Ottawa neighbourhood warrants attention, biostatistician says

Sep 08, 2016 | By Hillary Johnstone, CBC News | Since we published the CBC story of an Ottawa man looking for answers about a potential multiple sclerosis cluster, our inbox has been flooded with emails from people across the country, and around the world.

 Malaria stopped with single dose of new compound

September 7, 2016 | By Michelle Roberts, Health editor, BBC News | Scientists say they have found a new compound that stops malaria in animal studies with a single, low dose.  

 New vaccination strategies coach immune system to make HIV-neutralizing antibodies 

September 8, 2016 | International AIDS Vaccine Initiative | New approaches that could spur the human body to produce HIV-blocking antibodies have been successful in mice mimicking the human immune system, according to five new studies.

 Competition dates announced for Fall 2016 funding programs
After three months of criss-crossing BC, MSFHR's Research Programs team has completed initial consultations on the Foundation's new suite of funding programs.
Confirmed program launches:
Health Policy Fellowship 
Applications open: week of September 12 
Application deadline: first week of November

Convening & Collaborating Awards 
Applications open: week of September 26 
Application deadline: second week of October

2017 Scholar Program 
Guidelines posted: early September 
Applications open: early October 
Application deadline: TBD (deadline will be posted once confirmed)

For More Information please click here. 
Consulate of Canada will host a Canada Reception at BIO2017 in San Diego and we are looking for Sponsors
Note: There are a limited number Sponsorship Opportunities Available.

Get your Brand in front of Key Pharma and Biotech leaders.

This invitation-only reception honors and recognizes CEOs, public officials and dignitaries, and biotech companies and key organizations. 200 attendees are expected to attend this prestigious event. 

Sponsorships starting at the $3,000 CDN level include the benefits of:

* High visibility signage at reception and recognition on printed and electronic invitations
* 4 reception invitations
* Additional benefits include sponsor recognition in opening remarks by Canada's Consul 
General and signage on Canada's partnering meeting rooms at the Omni Hotel.

Take advantage of this elite, invitation-only reception to target your corporate message to a premier audience, including attending Canadian Ministers, top industry leaders, and special guests. 
If you are looking to raise the profile of your company and wish to participate as a sponsor, please contact Cheryl Rogers at before Sept 30th 2016.
Cheryl Rogers, Ph.D. 
Trade Commissioner 
Life Sciences, Medtech & Biofuels 
Consulate of Canada

Telephone: 1-(619)-615-4279 
402 W Broadway St., 4th floor 
San Diego, CA ,  92101 USA
Global Affairs Canada 
Life Science Career Opportunities

Did you know about our Business Solutions Program? Through our vendor partners, LifeSciences BC members can benefit from significant savings on a number of business services. For the full list of cost savings for members, please see:
Introducing the UPS® Members Benefit Program for Life Sciences BC Members
Take advantage of the UPS Members Benefit Program and save on a variety of UPS services! You'll receive 30% off small package shipments within Canada, to the U.S. and to worldwide destinations, 25% off imports into Canada, discounts starting at 70% off freight shipments and more.  
Save on office supplies and more with Grand & Toy

Through your Life Sciences BC membership, you can save 10%-20% off the web price of wide range of office supplies from Grand & Toy! Plus, there is no charge for next-business-day delivery on orders over $50 to most Canadian locations. (Some conditions apply.) 
Corporate discounts & group rates at The Listel Hotel

The Listel Hotel, a four star boutique hotel, is known for its enthusiastic service and commitment to high design and guest comfort. This intimate Robson street hotel boasts a perfect location with an award-winning restaurant Forage and gastro-pub Timber.
Suite 580 1285 West Broadway, 
Vancouver, BC V6H 3X8